TrkC plays an essential role in breast tumor growth and metastasis.
about
TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behaviormRNA expression of DOK1-6 in human breast cancermiR-200c targets a NF-κB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancerTrkC expression predicts favorable clinical outcome in invasive ductal carcinoma of breast independent of NT-3 expression.NTRK3 is a potential tumor suppressor gene commonly inactivated by epigenetic mechanisms in colorectal cancerTargeted PDT agent eradicates TrkC expressing tumors via photodynamic therapy (PDT)Rosamines targeting the cancer oxidative phosphorylation pathway.Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.Small Molecule Ligands For Active Targeting Of TrkC-expressing Tumor CellsTrkB Promotes Breast Cancer Metastasis via Suppression of Runx3 and Keap1 ExpressionDysregulated JAK2 expression by TrkC promotes metastasis potential, and EMT program of metastatic breast cancer.Double-targeting using a TrkC ligand conjugated to dipyrrometheneboron difluoride (BODIPY) based photodynamic therapy (PDT) agent.Tropomyosin Receptor Kinase C Targeted Delivery of a Peptidomimetic Ligand-Photosensitizer Conjugate Induces Antitumor Immune Responses Following Photodynamic TherapyTrkC promotes survival and growth of leukemia cells through Akt-mTOR-dependent up-regulation of PLK-1 and Twist-1.LINC00052 regulates the expression of NTRK3 by miR-128 and miR-485-3p to strengthen HCC cells invasion and migration.Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations.Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trialA novel microRNA located in the TrkC gene regulates the Wnt signaling pathway and is differentially expressed in colorectal cancer specimens.Small Molecules for Active Targeting in Cancer.Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model.Experimental verification of a conserved intronic microRNA located in the human TrkC gene with a cell type-dependent apoptotic function.TSPYL2 is an essential component of the REST/NRSF transcriptional complex for TGFβ signaling activationTrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts.Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity.Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy.CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling.TrkC promotes colorectal cancer growth and metastasis.Copy number variations of neurotrophic tyrosine receptor kinase 3 (NTRK3) may predict prognosis of ovarian cancer.Copy number analysis of ductal carcinoma in situ with and without recurrence.Experimental verification of a predicted novel microRNA located in human PIK3CA gene with a potential oncogenic function in colorectal cancer.Methylation and expression patterns of tropomyosin-related kinase genes in different grades of glioma.Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical Trial
P2860
Q24299955-06247650-01CD-4114-9E0C-4460A2B0246AQ33585060-D308D33A-F8A3-4937-B93E-1677DB405260Q34490836-EF90F240-2995-4B0B-B32A-FEC3B01D34DEQ34704932-DBF26889-C3A0-4DA1-AA86-F21129D22106Q34845629-4F9E7FFD-A8AF-4CD8-B0FB-640429289C6EQ34927053-DE2B6522-9679-45A5-A832-AD0855675A34Q35118967-ED2FF732-83A3-4AA6-858B-FAC566A8E7BFQ36545572-5EA9991B-5105-4FD0-B24D-234DDBECED60Q36600240-6CADA54C-1504-4517-B456-296B932E7E14Q36693852-2A839BA9-4F32-4562-BEA5-4AAE329132ABQ37274117-CD2F3A9E-CFEC-4D19-963D-A27B11D999EEQ37335035-C7F86B35-B552-42FE-B409-C4D221615113Q37419153-C2D46E35-FE52-4C24-9E51-0299BFC27B1BQ37462530-2CDD253E-4CAC-49FB-A52B-7D93DA0A0B64Q37565216-4D389B53-FDA1-435D-B031-AD6F09E58E43Q37633558-A7BB5DE4-D97A-481A-BDA6-9EF7EFCEE9E9Q37686415-B6226502-77B7-4E12-848A-FA39432FED67Q38720651-6CDB20D7-B6BC-4091-BD59-B1CF8CD68393Q38780383-C3052953-C767-4D4B-9791-AC834440B3E3Q38800617-4CEFD5F8-3625-4852-AD20-18BA9B9DCD43Q38899793-F9E2099A-CF5E-4F32-8C35-FBFE1BFE606EQ38917380-A629C81D-7E09-49A3-B054-1B1E84C55AABQ38940598-ED5AEC0E-5131-4083-AB1E-A2ACA11E3A08Q38974959-CCE30C1A-BDA3-43C8-933C-ED88A5D3B8EEQ39187880-33842E1D-D9A8-4BE3-ADAD-4293C1BAFE0FQ39400779-EDE1AB79-233C-499B-9873-4609325B2F5CQ41093090-B397F068-23D8-4714-A2B9-E8D187253716Q42280294-41253064-AAD7-4704-A4F4-764C65B7CA40Q48140150-F27F6C93-D35C-476D-A0A9-A5862E89C818Q51579114-0B4037C9-9BA5-4838-8AAB-4C59A843B1EFQ54351815-3DF31C7D-645B-4CAC-83D5-ED3AB8AC5E75Q57172993-4A44B1E5-5346-4AA0-84D2-B772E77E4202
P2860
TrkC plays an essential role in breast tumor growth and metastasis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
TrkC plays an essential role in breast tumor growth and metastasis.
@en
TrkC plays an essential role in breast tumor growth and metastasis.
@nl
type
label
TrkC plays an essential role in breast tumor growth and metastasis.
@en
TrkC plays an essential role in breast tumor growth and metastasis.
@nl
prefLabel
TrkC plays an essential role in breast tumor growth and metastasis.
@en
TrkC plays an essential role in breast tumor growth and metastasis.
@nl
P2093
P2860
P356
P1433
P1476
TrkC plays an essential role in breast tumor growth and metastasis.
@en
P2093
Chohee Yun
Gyoung Mi Kim
Jeong-Seok Nam
Joon Jeong
Mi Hee Lim
Min Soo Kim
Seong-Jin Kim
P2860
P304
P356
10.1093/CARCIN/BGQ180
P407
P577
2010-08-28T00:00:00Z